Drug Actually Repairs Nerve Damage, Giving Scientists Hope For Future MS Treatment

Drug Actually Repairs Nerve Damage, Giving Scientists Hope For Future MS Treatment

In a recent phase 2 clinical trial, the cancer drug bexarotene was found to regenerate the myelin sheath—the target of the autoimmune disorder multiple sclerosis, or MS. A protective lipid layer around nerves in the brain and spinal cord, the myelin sheath is targeted by immune cells incorrectly in patients with MS, resulting in the […]

The post Drug Actually Repairs Nerve Damage, Giving Scientists Hope For Future MS Treatment appeared first on Good News Network.


Source: Good News